Teva Pharmaceutical Industries Ltd. announced on Monday that its glatiramer acetate injection was approved by the Japanese Ministry of Health, Labour and Welfare (MHLW)…
Eli Lilly and Company and Incyte Corporation have announced positive top-line results of RA-BEGIN, the third Phase 3 study evaluating the safety and efficacy of baricitinib, an investigational medicine for patients with moderately-to-severely active rheumatoid arthritis (RA).
Hikma Pharmaceuticals PLC, a multinational pharmaceutical group, has agreed to acquire 98.09% of the share capital of EIMC United Pharmaceuticals (EUP) from a consortium of shareholders. Hikma said in an announcement on September 8, 2015 acquiring EUP would strenghten its position in the large and fast growing Egyptian market. EUP is a pharmaceutical manufacturing company specialising in oncology…
Pharmaceutical Daily 